Technical Analysis for OVIT - Oncovista Innovative Therapies I

Grade Last Price % Change Price Change
grade C 0.0249 64.90% 0.0098
OVIT closed up 64.9 percent on Wednesday, January 22, 2020, on 4 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical OVIT trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
BB Squeeze Ended Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish 64.90%
Fell Below 50 DMA Bearish 64.90%
Bollinger Band Squeeze Range Contraction 64.90%
Wide Bands Range Expansion 64.90%
Gapped Down Weakness 64.90%
Older signals for OVIT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

OncoVista Innovative Therapies, Inc. is a biopharmaceutical company. The Company is engaged in developing targeted anticancer therapies by utilizing tumor-associated biomarkers. The Company's product pipeline consists of advanced (Phase II) and early (Phase I) clinical-stage compounds, late preclinical drug candidates and early preclinical leads. The Company's therapeutic strategy is based on targeting the patient's tumors with treatments that will deliver drugs selectively based upon specific biochemical characteristics of the cancer cells comprising the tumor. The Company's products include: Cordycepin (OVI-123) and L-Nucleoside Conjugates (OVI-117). Cordycepin depends upon the presence of a DNA polymerase, known as terminal deoxynucleotidyl transferase (TdT), for its therapeutic activity. OVI-117 is a thymidylate synthase (TS) inhibitor with pharmacological properties, which results in a retention of efficacy and a reduction of toxicity.
Medicine Biotechnology Branches Of Biology Cancer Biopharmaceutical Clinical Medicine Tumor Biomarkers Chemical Pathology Cordycepin Polymerase

Is OVIT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.0625
52 Week Low 0.0065
Average Volume 27,480
200-Day Moving Average 0.0286
50-Day Moving Average 0.0230
20-Day Moving Average 0.0190
10-Day Moving Average 0.0195
Average True Range 0.0066
ADX 21.44
+DI 34.6028
-DI 21.0011
Chandelier Exit (Long, 3 ATRs ) 0.0081
Chandelier Exit (Short, 3 ATRs ) 0.0348
Upper Bollinger Band 0.0273
Lower Bollinger Band 0.0107
Percent B (%b) 0.86
BandWidth 87.3684
MACD Line -0.0004
MACD Signal Line -0.0010
MACD Histogram 0.0006
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0323
Resistance 3 (R3) 0.0314 0.0282 0.0310
Resistance 2 (R2) 0.0282 0.0263 0.0286 0.0306
Resistance 1 (R1) 0.0265 0.0251 0.0274 0.0274 0.0302
Pivot Point 0.0233 0.0233 0.0237 0.0237 0.0233
Support 1 (S1) 0.0216 0.0214 0.0225 0.0225 0.0196
Support 2 (S2) 0.0184 0.0202 0.0188 0.0192
Support 3 (S3) 0.0167 0.0184 0.0188
Support 4 (S4) 0.0176